Topic: venture capital (VC)
The round moves the total raised by the company past the $200 million mark and values it at around $2 billion.
The cash sets ex-Novartis executive Usman “Oz” Azam up to hustle Tmunity's pipeline of T cell-based immunotherapies through clinical development.
The Sofinnova-led round will support trials of LimFlow's device, which diverts blood around diseased arteries to save patients and their limbs.
The cash sets Intact up to advance a clinical development program designed to generate data to support FDA approval of the Tack Endovascular System.
The financing will see Inventiva through a period in which it will drop data from a phase 2b NASH trial and a two-year carcinogenicity study.
The financing tees up Enterprise to take three projects into the clinic and push one of them through a midphase proof-of-concept trial.
The money will support trials of patient monitoring tools Kaiku and its investors think could improve outcomes in cancer and other indications.
Amgen joined with MP Healthcare Venture Management and Alexandria Venture Investments to put the latest tranche of funding into QurAlis.
The financing comes as Axonics closes in on the end of a clinical trial that will set it up to market the device in the U.S.
The vehicle sets Sofinnova up to invest in 15 late-stage private and public drug and medical device companies.